Updated employee announcements, business news and recognition in the industry today.
People
Cliff Echols
SCORR Marketing, a global health science marketing and communications firm, has announced the addition of three employees--Cliff Echols as market intelligence director; and Kerry Hutchings and Cherie Squires as senior directors of program management.
Kerry Hutchings
TFS International, a Sweden-based, global mid-size CRO, has appointed Birgitte Volck, MD, PhD, as a non-executive Director to serve on the Company's Board of Directors. Dr. Volck is the Senior Vice President, Head of R&D Rare Disease at GlaxoSmithKline in the UK. Schulman IRB, a central IRB, announced Michele Russell-Einhorn, JD, will join the organization September 1, 2016, as Vice President for Oncology Services. Russell-Einhorn currently is Senior Director of Dana-Farber Cancer Institute’s Office for Human Research Studies. At Schulman IRB, she will build and lead the company’s forthcoming Central Oncology Review (COR) division, launching later in 2016.
Cherie Squires
Business News Dr Rabinder Buttar, founder and CEO of ClinTec International, joined an industry-leading expert panel of judges for the eighth round final of the Scottish EDGE competition, which identifies and supports Scotland’s up-and-coming, innovative, high-growth generating entrepreneurial talent. Recognition Q2 Solutions, a global clinical trials laboratory services organization and joint venture of Quest and Quintiles, has received the 2016 Lilly Global Supplier Award. Q2 Solutions was one of 12 companies to receive the award this year, recognizing the company’s ongoing contributions to Lilly’s drug development efforts. ClinCapture, a provider of free and validated electronic data capture (EDC) software, announced its nomination for a Bronze 2016 Stevie Award by the American Business Awardsâ in the Cloud Application/Service as well as the Software Development Solution Website category.
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Managing Side Effects and Dosing in Off-Label GLP-1 Use with Help from Real-World Evidence
July 18th 2025Shipra Patel, global therapeutic area section head, endocrinology, global head, pediatrics, Parexel, explains how real-world data is helping researchers navigate gastrointestinal side effects, dose flexibility, and long-term tolerability in off-label GLP-1 use.
Anselamimab Misses Primary Endpoint in Phase III CARES Trials for AL Amyloidosis
July 17th 2025In the Phase III CARES trials, anselamimab did not meet the primary endpoint for advanced-stage AL amyloidosis, but a prespecified subgroup analysis revealed meaningful improvements in survival and cardiovascular outcomes.